Therapeutics ID Nelson Answers – Flashcards
Unlock all answers in this set
Unlock answersPathogens of Encephalitis |
Viral
Bacterial Neonates: Group B Streptococcus, Listeria monocytogenes, Citrobacter Others: Borrelia burgdorferi, Bartonella henselae, Rickettsia rickettsii, Mycoplasma pneumoniae |
Clinical Presentation of Encephalitis |
|
Encephalitis Diagnosis |
|
Encephalitis CNS Findings |
|
Encephalitis Treatment |
Support Measures
Empiric Acyclovir
|
Signs/Symptoms of Bacterial Meningitis |
|
Physical Exam for Bacterial Meningitis |
Kernig's Sign Brudzinski's Neck Sign
Both will hurt if they have meningitis |
Most Common Bacterial Pathogens of Meningitis |
|
Normal CSF Lab Results |
WBCs < 5 (adults) < 20 (newborns)
Diff 70% Lymphocytes 30% Monocytes Protein < 50
Glucose 2/3 serum |
Bacterial Meningitis Lab Results |
WBCs 400-100,000
Diff 80-90% Neutrophils (PMNs)
Protein Mild to marked elevation (80-500)
Glucose < 1/2 serum |
Top 3 Infectious Bacteria that cause Meningitis in Neonates |
|
Characteristics of Pneumococcal Meningitis |
Streptococcus pneumoniae Most Common Meningitis
Known to Affect:
Causes neurologic damage (deafness to severe brain damage)
|
Characteristics of Meningococcal Meningitis |
|
Clinical Signs of Meningococcal Meningitis |
|
Group B Strep Meningitis |
Streptococcus agalactiae
|
Listeria Meningitis |
|
Aerobic G- Bacilli that cause Meningitis |
In Neonates
Head trauma or Neurosurgery Patients
|
Empiric Meningitis Therapy: < 1 month Common Bacteria and Treatment |
S. agalactiae E. coli Listeria monocytogenes Klebsiella
Ampicillin + Cefotaxime or Aminoglycoside |
Empiric Meningitis Therapy: 1-23 months Common Bacteria and Treatment |
S. pneumoniae Neisseria meningitidis S. agalactiae H. influenzae type B E. coli
Vancomycin + Ceftriaxone or Cefotaxime |
Empiric Meningitis Therapy: 2-50 yrs Common Bacteria and Treatment |
N. meningitidis S. pneumoniae
Vancomycin + Ceftriaxone or Cefotaxime |
Empiric Meningitis Therapy: > 50 yrs Common Bacteria and Treatment |
S. pnuemoniae N. meningitidis Listeria monocytogenes Aerobic G- bacilli
Vancomycin + Ampicillin + Ceftriaxone or Cefotaxime |
Empiric Meningitis Therapy: Basilar Skull Fracture Common Bacteria and Treatment |
S. pneumoniae H. influenzae Group A Streptococcus pyogenes
Vancomycin + Ceftriaxone or Cefotaxime |
Empiric Meningitis Therapy: Penetrating Head Trauma Common Bacteria and Treatment |
Staph. aureus Coagulase - Staph. Aerobic G - (including P. aeruginosa)
Vancomycin + Cefepime, Ceftazidime, or Meropenem
Important to cover for MRSA and P. aeruginosa
|
Empiric Meningitis Therapy: Post-Neurosurgery Common Bacteria and Treatment |
Aerobic G- bacilli Staph. aureus Coagulase - Staph.
Vancomycin + Ceftazidime, Cefepime, or Meropenem
Important to cover MRSA and P. aeruginosa |
Empiric Meningitis Therapy: CSF Shunt Common Bacteria and Treatment |
Coagulase - Staph. Staph. aureus Aerobic G- bacilli Propionibacterium acnes
Vancomycin + Cefepime, Ceftazidime, or Meropenem
Important to cover MRSA and P. aeruginosa |
Targeted Therapy for Meningitis Streptococcus pneumoniae |
Vancomycin + 3rd Gen Cephalosporin |
Targeted Therapy for Meningitis Neisseria meningitidis |
3rd Gen Cephalosporin |
Targeted Therapy for Meningitis Listeria monocytogenes |
Ampicillin OR Penicillin G
Consider adding an aminoglycoside to these |
Targeted Therapy for Meningitis Streptococcus agalactiae |
Ampicillin OR Penicillin G
Consider adding an aminoglycoside to these |
Targeted Therapy for Meningitis Haemophilus influenzae |
3rd Gen Cephalosporin |
Targeted Therapy for Meningitis Escherichia coli |
3rd Gen Cephalosporin |
Antibiotic CSF Penetration: Able to achieve Therapeutic Concentrations |
|
Antibiotic CSF Penetration: Not able to achieve Therapeutic Concentrations |
|
Antibiotic CSF Penetration: Good if inflammation present |
|
3 Baseline Clinical Features Associated with Adverse Outcomes |
|
Length of Therapy: Neisseria meningitidis |
7 days |
Length of Therapy: Haemophilus influenzae |
7 days |
Length of Therapy: Streptococcus pneumoniae |
10-14 days |
Length of Therapy: Streptococcus agalaciae |
14-21 days |
Length of Therapy: Aerobic G- Bacilli |
21 days |
Length of Therapy: Listeria monocytogenes |
> 21 days |
In Meningitis, what criteria must be met before the patient can be considered for outpatient therapy? |
|
Vaccine Prevention: Haemophilus influenzae type B |
Infants |
Vaccine Prevention: Streptococcus pneumoniae |
Infants - haven't completed vaccine series Elderly - vaccine may be decreasing in effect |
Vaccine Prevention: Neisseria meningitidis |
Teenagers |